Hematologic Diseases
Pipeline by Development Stage
Competitive Landscape
17 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (10)
Total enrollment: 13,666 patients across 10 trials
Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients
Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants
A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients
Safety and Tolerability Evaluation of MaaT033
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation
Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer
Progression of Hematopoietic Diseases in Shanghai, China
Molecular Epidemiology of Benzene-exposed Workers.
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.